HBME-1 immunostaining in thyroid pathology;Intérêt de l'HBME-1 en pathologie thyroïdienne

Annales de Pathologie

Volumn 21, Issue 1, 2001, Pages 15-20

  Rigau, Valérie ^a   Martel, Bertrand ^a   Evrard, Claude ^a   Rousselot, Pierre ^a   Galateau Salle, Françoise ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Follicular carcinoma; HBME 1; Nodular goiter; Papillary carcinoma; Tall cell carcinoma; Thyroid neoplasms

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HBME 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLICULAR CARCINOMA; GOITER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; THYROID CARCINOMA; THYROID DISEASE;

ADENOCARCINOMA, FOLLICULAR; ANTIBODIES, MONOCLONAL; ANTIGENS; CARCINOMA, PAPILLARY; EPITHELIUM; GOITER; HUMANS; IMMUNOHISTOCHEMISTRY; THYROID DISEASES; THYROID NEOPLASMS;

EID: 0035106490     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Endocrine gland cancer
2. Pronostic factors for thyroid carcinoma a population based study of 15.698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991
3. Prognostic factors in papillary carcinoma of the thyroid
4. Long term results and pronostic factors in patients with differentiated thyroid carcinoma
5. Classification et épidémiologie des tumeurs thyroïdiennes
6. Le carcinome papillaire de la thyroide: Ėvolution des critėres histologiques du diagnostic
7. Papillary carcinoma of thyroid: Classical and variants
8. Carcinomes thyroïdiens différenciés d'origine folliculaire: Faits nouveaux en 1988
9. Follicular variant of papillary thyroid carcinoma: A clinicopathologic study
10. Tall cell variant of papillary carcinoma. A reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid
11. Tall cell variant of papillary thyroid cancer: Disregarded entity?
12. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods
13. Microcancer thyroïdien
14. Immunohistochimie des carcinomes thyroïdiens
15. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinoma and follicular thyroid adenoma
16. Differential reactivity of HBME-1 and CD 15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours
17. Immunocytochemical evaluation of HBME-1, CA19-9, and CD15 (Leu-M1) in fine needle aspirates of thyroid nodules
18. HBME-1 immunostaining in thyroid fine needle aspirations A useful marker in the diagnosis of carcinoma
19. Immunohistochemical and molecular studies as an aid to the diagnosis of malignant mesothelioma
20. L'examen extemporané en pathologie thyroidienne. Pourquoi et comment?
21. Papillary carcinoma
22. Follicular carcinoma
23. Follicular adenoma
24. The WHO histological classification of thyroid tumors: A commentary on the second edition
25. Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase technics: A comparison between ABC and unlabeted antibody (PAP) procedures
26. Monoclonal antibodies against mesothelial membrane antigen discriminate between mesothelioma and lung adenocarcinoma
27. HBME-1 A monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft tissue and bone tumors
28. Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility
29. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications